首页 | 本学科首页   官方微博 | 高级检索  
检索        

桥甲方颗粒治疗桥本甲状腺炎的临床研究
引用本文:张丹,郑敏,范朝华,杨宏杰.桥甲方颗粒治疗桥本甲状腺炎的临床研究[J].上海中医药杂志,2018,52(1):51-53.
作者姓名:张丹  郑敏  范朝华  杨宏杰
作者单位:上海中医药大学附属岳阳中西医结合医院
基金项目:上海市教委科研基金项目(2012JW49)
摘    要:目的观察中药复方桥甲方颗粒对桥本甲状腺炎的临床疗效。方法 70例患者随机分为桥甲方组和硒酵母片组,每组各35例。桥甲方组给予桥甲方颗粒剂口服,硒酵母片组给予硒酵母片口服,两组疗程均为12周,观察治疗前后甲状腺功能血清游离三典甲状腺原氨酸(FT3)、血清游离甲状腺素(FT4)、血清促甲状腺素(TSH)]及甲状腺相关抗体水平甲状腺过氧化物酶抗体(TPOAb)、甲状腺球蛋白抗体(TGAb)、促甲状腺素受体抗体(TRAb)],并进行中医证候疗效评价。结果两组治疗前后甲状腺功能FT_3、FT_4、TSH均无明显变化(P0.05);桥甲方组治疗后TPOAb、TGAb较治疗前明显下降(P0.05),TRAb无明显改变;而硒酵母片组治疗后TPOAb、TGAb、TRAb水平与治疗前相比无统计学意义(P0.05);桥甲方在降低TPOAb、TGAb水平上优于硒酵母片组(P0.05);桥甲方组中医证候疗效明显优于硒酵母片组(P0.01)。结论中药复方桥甲方颗粒可明显降低桥本甲状腺炎患者的相关抗体水平,疗效优于硒酵母片组。

关 键 词:桥本甲状腺炎  桥甲方颗粒  甲状腺相关抗体
收稿时间:2017/9/10 0:00:00

Clinical study of Qiaojiafang Granule in the treatment of Hashimoto thyroiditis
ZHANG Dan,ZHENG Min,FAN Zhaohua and YANG Hongjie.Clinical study of Qiaojiafang Granule in the treatment of Hashimoto thyroiditis[J].Shanghai Journal of Traditional Chinese Medicine,2018,52(1):51-53.
Authors:ZHANG Dan  ZHENG Min  FAN Zhaohua and YANG Hongjie
Institution:Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China,Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China,Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China and Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China
Abstract:  Objective:To observe the clinical efficacy of Qiaojiafang Granule on Hashimoto thyroiditis. Methods70 patients were randomly divided into the Qiaojiafang Granule(QJF)group and selenium yeast tablet(SY)group,35 cases in each group. The treatment group was orally treated with Qiaojiafang Granule, and the control group was orally treated with selenium yeast tablet. The treatment course was 12 weeks in both groups. The thyroid function indexes including serum free triiodothyronine (FT3),serum free thyroxine(FT4) and thyrotropin(TSH),and the levels of thyroid associated antibodies including thyroid peroxidase antibody(TPOAb),thyroglobulin antibody(TGAb)and thyrotropin receptor antibody(TRAb)were observed before and after treatment. And the clinical efficacy was evaluated.  Results:Compared with treatment before,there were no obvious changes on the levels of FT3,FT4 and TSH in both groups after treatment(P>0.05). Compared with treatment before,the levels of TPOAb and TGAb were obviously decreased in the QJF group after treatment(P<0.05),but no obvious change on TRAb level was observed. In the SY group,there were no statistically significant differences on the levels of TPOAb,TGAb and TRAb between treatment before and after(P>0.05). After treatment,the levels of TPOAb and TGAb in the QJF group were lower than those in the SY group(P<0.05). The clinical efficacy on Chinese medical syndrome of the QJF group was obviously better than that of the SY group(P<0.01).  Conclusion:Qiaojiafang Granule can obviously reduce the levels of thyroid associated antibodies in patients with Hashimoto thyroiditis,and its efficacy is better than selenium yeast tablet.
Keywords:
本文献已被 CNKI 等数据库收录!
点击此处可从《上海中医药杂志》浏览原始摘要信息
点击此处可从《上海中医药杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号